Shandong Shanda Wit Science and Technology Co Ltd (000915) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has a cash flow conversion efficiency ratio of 0.152x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥620.45 Million ≈ $90.79 Million USD) by net assets (CN¥4.08 Billion ≈ $596.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000915 market cap for the company's overall valuation and market capitalisation.
Shandong Shanda Wit Science and Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Shanda Wit Science and Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Shandong Shanda Wit Science and Technolo to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kri-Kri Milk Industry S.A
AT:KRI
|
0.059x |
|
Shenzhen Comix Group Co Ltd
SHE:002301
|
0.017x |
|
Festi hf
IC:FESTI
|
-0.001x |
|
Jilin Forest
SHG:600189
|
0.056x |
|
Orient International Enterprise Ltd
SHG:600278
|
0.007x |
|
Zhejiang Qianjiang Motorcycle Co Ltd
SHE:000913
|
0.000x |
|
Logwin AG
XETRA:TGHN
|
0.123x |
|
RHI MAGNESITA INDIA LIMITED
NSE:RHIM
|
0.017x |
Annual Cash Flow Conversion Efficiency for Shandong Shanda Wit Science and Technology Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Shanda Wit Science and Technology Co Ltd from 1998 to 2024. View Shandong Shanda Wit Science and Technolo (000915) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.41 Billion ≈ $645.68 Million |
CN¥929.61 Million ≈ $136.03 Million |
0.211x | -19.35% |
| 2023-12-31 | CN¥4.50 Billion ≈ $658.00 Million |
CN¥1.17 Billion ≈ $171.89 Million |
0.261x | -11.32% |
| 2022-12-31 | CN¥4.06 Billion ≈ $594.32 Million |
CN¥1.20 Billion ≈ $175.07 Million |
0.295x | +32.48% |
| 2021-12-31 | CN¥3.40 Billion ≈ $497.44 Million |
CN¥755.85 Million ≈ $110.61 Million |
0.222x | -11.27% |
| 2020-12-31 | CN¥2.94 Billion ≈ $429.52 Million |
CN¥735.55 Million ≈ $107.63 Million |
0.251x | +164.15% |
| 2019-12-31 | CN¥2.57 Billion ≈ $375.65 Million |
CN¥243.54 Million ≈ $35.64 Million |
0.095x | -58.77% |
| 2018-12-31 | CN¥2.34 Billion ≈ $342.53 Million |
CN¥538.56 Million ≈ $78.81 Million |
0.230x | +19.80% |
| 2017-12-31 | CN¥2.22 Billion ≈ $324.66 Million |
CN¥426.11 Million ≈ $62.35 Million |
0.192x | -25.26% |
| 2016-12-31 | CN¥1.95 Billion ≈ $285.25 Million |
CN¥500.91 Million ≈ $73.30 Million |
0.257x | +48.70% |
| 2015-12-31 | CN¥1.68 Billion ≈ $245.77 Million |
CN¥290.24 Million ≈ $42.47 Million |
0.173x | -5.97% |
| 2014-12-31 | CN¥1.48 Billion ≈ $216.90 Million |
CN¥272.41 Million ≈ $39.86 Million |
0.184x | -1.32% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.76 Million |
CN¥216.05 Million ≈ $31.62 Million |
0.186x | +7.77% |
| 2012-12-31 | CN¥946.05 Million ≈ $138.44 Million |
CN¥163.48 Million ≈ $23.92 Million |
0.173x | -4.43% |
| 2011-12-31 | CN¥769.24 Million ≈ $112.56 Million |
CN¥139.09 Million ≈ $20.35 Million |
0.181x | -38.03% |
| 2010-12-31 | CN¥649.52 Million ≈ $95.05 Million |
CN¥189.51 Million ≈ $27.73 Million |
0.292x | +18.77% |
| 2009-12-31 | CN¥526.71 Million ≈ $77.07 Million |
CN¥129.39 Million ≈ $18.93 Million |
0.246x | +16.04% |
| 2008-12-31 | CN¥443.06 Million ≈ $64.83 Million |
CN¥93.80 Million ≈ $13.73 Million |
0.212x | -17.66% |
| 2007-12-31 | CN¥393.55 Million ≈ $57.59 Million |
CN¥101.20 Million ≈ $14.81 Million |
0.257x | +79.88% |
| 2006-12-31 | CN¥363.40 Million ≈ $53.18 Million |
CN¥51.95 Million ≈ $7.60 Million |
0.143x | -22.52% |
| 2005-12-31 | CN¥343.51 Million ≈ $50.27 Million |
CN¥63.38 Million ≈ $9.27 Million |
0.184x | +87.65% |
| 2004-12-31 | CN¥310.43 Million ≈ $45.43 Million |
CN¥30.52 Million ≈ $4.47 Million |
0.098x | +1111.11% |
| 2003-12-31 | CN¥299.64 Million ≈ $43.85 Million |
CN¥2.43 Million ≈ $355.95K |
0.008x | +112.45% |
| 2002-12-31 | CN¥253.39 Million ≈ $37.08 Million |
CN¥-16.53 Million ≈ $-2.42 Million |
-0.065x | -11925.11% |
| 2001-12-31 | CN¥245.49 Million ≈ $35.92 Million |
CN¥-133.16K ≈ $-19.49K |
-0.001x | +99.84% |
| 2000-12-31 | CN¥258.69 Million ≈ $37.85 Million |
CN¥-90.48 Million ≈ $-13.24 Million |
-0.350x | -303.55% |
| 1999-12-31 | CN¥262.99 Million ≈ $38.48 Million |
CN¥45.19 Million ≈ $6.61 Million |
0.172x | -12.93% |
| 1998-12-31 | CN¥122.61 Million ≈ $17.94 Million |
CN¥24.20 Million ≈ $3.54 Million |
0.197x | -- |
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more